Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Current Taxes (2016 - 2025)

Historic Current Taxes for Outlook Therapeutics (OTLK) over the last 8 years, with Q4 2025 value amounting to $302000.0.

  • Outlook Therapeutics' Current Taxes fell 8373.4% to $302000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $302000.0, marking a year-over-year decrease of 8373.4%. This contributed to the annual value of $302000.0 for FY2025, which is N/A changed from last year.
  • Per Outlook Therapeutics' latest filing, its Current Taxes stood at $302000.0 for Q4 2025, which was down 8373.4% from $302000.0 recorded in Q3 2025.
  • In the past 5 years, Outlook Therapeutics' Current Taxes ranged from a high of $1.9 million in Q4 2024 and a low of $302000.0 during Q3 2025